# Batch Risk of Bias Eval Report

This report contains an audit trace: explicit extracted evidence, model-provided rationales, and label comparisons. It does not include hidden chain-of-thought.

- Studies: 4
- Domains: 20
- Accuracy: 11/20 (55.0%)

## Summary

| PMID | Study | Correct | Accuracy | Seconds |
|---|---|---:|---:|---:|
| 19487623 | King 2009 | 3/5 | 60.0% | 96.06 |
| 20579848 | Palacios 2009 | 2/5 | 40.0% | 131.03 |
| 21775755 | Ziegler 2011 | 4/5 | 80.0% | 146.95 |
| 22928960 | Houry 2012 | 2/5 | 40.0% | 140.55 |

## Error Types

- over-inferred_from_sparse_reporting: 4
- under-called_due_to_missing_or_underused_evidence: 4
- blinding_outcome_type_or_role_confusion: 1

## 19487623 - King 2009

- Mode: strict
- Review context: none (0 chars)
- Article chars: 24566
- Extraction context chars: 12006
- Total seconds: 96.06

### Methodology Extraction

- `randomization_method`: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).
- `allocation_concealment_method`: Not reported
- `blinding_participants`: Not reported
- `blinding_personnel`: The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated. Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events.
- `blinding_outcome_assessors`: Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events.
- `attrition_details`: 149 were randomized to receive citalopram (n=73) or placebo (n=76). Most participants (82.6%) completed the 12-week trial. In the citalopram-treated group, 12.3% stopped early due to adverse events and another 2.7% withdrew consent; in the placebo group, 9.2% left early owing to adverse events and another 6.6% withdrew consent. For subjects who failed to complete all postrandomization assessments, the last observation was carried forward.
- `study_design`: Randomized, placebo-controlled, parallel-group trial (individual RCT).
- `additional_notes`: Liquid citalopram was used and placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications. All efficacy and safety analyses used the intent-to-treat principle. Evaluating clinicians from all sites were trained to reliability on the CYBOCS-PDD, CGI-I, and Clinical Global Impressions, Severity of Illness Scale at the beginning and midpoint of the trial.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |
| Allocation concealment | Unclear risk | Unclear risk | yes |  |
| Blinding of participants and personnel: All outcomes | Low risk | Low risk | yes |  |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: The investigators explicitly report a random component (permuted block randomization with randomly varying block sizes), which meets the criteria for low risk of bias for sequence generation.
- Model support: Quote: "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years)." Comment: This description indicates a random component (permuted block randomization with randomly varying block sizes), so sequence generation was adequately random. Probably done.
- Model support context: [{"source": "methodology", "quote": "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).", "relevance": "Direct description of the random sequence generation method showing use of a random process (permuted blocks with randomly varying block sizes)."}]
- GT support: Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years)
- Evidence row: {}
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Unclear risk
- Match: True
- Model rationale: Because the trial reports a detailed randomization scheme but provides no information on how allocation was concealed from those enrolling participants, it is unclear whether assignment could have been foreseen; per Cochrane criteria this warrants an 'Unclear risk' judgement.
- Model support: Comment: Allocation concealment not reported in the article; randomization method (permuted blocks with varying block sizes stratified by site and age) is described but there is no information on procedures to prevent foreknowledge of upcoming assignments (e.g. central randomization or sealed opaque envelopes).
- Model support context: [{"source": "methodology", "quote": "Participants were randomly assigned to citalopram or placebo using permuted blocks with randomly varying block sizes stratified by site and by age (5-11 vs 12-17 years).", "relevance": "Describes the random sequence generation but does not address how allocations were concealed from those enrolling participants."}, {"source": "methodology", "quote": "allocation_concealment_method: Not reported", "relevance": "Explicit statement that allocation concealment procedures were not described, leaving uncertainty about whether recruiters could foresee assignments."}, {"source": "methodology", "quote": "Liquid citalopram was used and placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications.", "relevance": "Describes matching of study medication but pertains to blinding of participants/personnel...
- GT support: Details not provided
- Evidence row: {}
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: A matched placebo was used and evaluators were masked; although some clinicians managed dosing and recorded AEs, the credible placebo and masked outcome assessment make it unlikely that knowledge of allocation materially influenced outcomes, meeting criteria for Low risk.
- Model support: Quote: "Liquid citalopram was used and placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications." Comment: The trial used a matched placebo and evaluating clinicians were masked; participants and clinicians who adjusted dose had limited ability to distinguish treatments, so performance bias is unlikely to have materially influenced outcomes. Probably done.
- Model support context: [{"source": "methodology", "quote": "Liquid citalopram was used and placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications.", "relevance": "Shows use of a credible placebo matching sensory characteristics, supporting participant blinding."}, {"source": "methodology", "quote": "Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events.", "relevance": "Indicates outcome assessors were masked, reducing risk of performance/detection bias for efficacy outcomes."}, {"source": "methodology", "quote": "The treating clinician reviewed efficacy ratings, monitored and recorded adverse events, and subsequently adjusted the medication dosage as clinically indicated.", "relevance": "Though some treating clinicians adjusted dosage and...
- GT support: Two masked clinicians met with participants during each scheduled evaluation
- Evidence row: {}
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: Assessing clinicians were explicitly described as masked for efficacy assessments and placebo was matched to active drug, so outcome assessment was blinded and unlikely to have been broken; therefore detection bias is at low risk.
- Model support: Quote: "Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events." Comment: The trial reports that outcome evaluations were conducted by masked (blinded) clinicians who monitored efficacy ratings; this indicates that outcome assessment was blinded, making it unlikely that assessor knowledge of allocation biased outcome measurement. Probably done.
- Model support context: [{"source": "methodology", "quote": "Two masked clinicians met with participants during each scheduled evaluation. The evaluating clinician monitored efficacy and was blinded to adverse events.", "relevance": "Direct statement that outcome assessors were masked supports low detection bias for all outcomes assessed by these clinicians."}, {"source": "methodology", "quote": "Liquid citalopram was used and placebo matched for smell, taste, and viscosity was prepared at each site's pharmacy according to study specifications.", "relevance": "Credible placebo matching reduces chance that assessors (or participants) could infer allocation, supporting maintenance of blinding."}]
- GT support: The evaluating clinician monitored efficacy and was blinded to AEs
- Evidence row: {}
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: Overall attrition was moderate and similar across arms with similar reasons (AEs and withdrawal); although LOCF was used (a simple imputation), the balanced and limited amount of missing data makes material bias unlikely, satisfying criteria for Low risk.
- Model support: Quote: "Most participants (82.6%) completed the 12-week trial. In the citalopram-treated group, 12.3% stopped early due to adverse events and another 2.7% withdrew consent; in the placebo group, 9.2% left early owing to adverse events and another 6.6% withdrew consent. For subjects who failed to complete all postrandomization assessments, the last observation was carried forward." Comment: Attrition was moderate (≈17.4% overall), reasonably balanced between groups with similar reasons for missingness (adverse events and withdrawal of consent), and an ITT approach with LOCF was used. Given balanced attrition and that reasons are unlikely to be strongly related in a way that would bias between-group comparisons materially, this is judged Low risk.
- Model support context: [{"source": "methodology", "quote": "Most participants (82.6%) completed the 12-week trial. In the citalopram-treated group, 12.3% stopped early due to adverse events and another 2.7% withdrew consent; in the placebo group, 9.2% left early owing to adverse events and another 6.6% withdrew consent. For subjects who failed to complete all postrandomization assessments, the last observation was carried forward.", "relevance": "Provides the numbers and reasons for attrition, balance across groups, and how missing data were handled (LOCF/ITT)."}]
- GT support: LTFU citalopram: 13 withdrew, 1 due to serious AE; 8 AEs; 2 protocol violations; 2 consent withdrawn LTFU placebo: 13 withdrawn, 7 AEs; 1 protocol violation; 5 consent withdrawn
- Evidence row: {}
- Source context preview: 


## 20579848 - Palacios 2009

- Mode: strict
- Review context: none (0 chars)
- Article chars: 25127
- Extraction context chars: 12003
- Total seconds: 131.03

### Methodology Extraction

- `randomization_method`: Not reported
- `allocation_concealment_method`: Not reported
- `blinding_participants`: Quote: "We conducted a single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial for 21 wk..."
- `blinding_personnel`: Not reported
- `blinding_outcome_assessors`: Quote: "Measurements were taken while subjects wore light clothing, no shoes or accessories, by the CRC-trained personnel, who were blinded to the study treatments."
- `attrition_details`: Quote: "Of the 46 subjects recruited, 10 did not qualify due to a calcium intake above 700 mg/d and 6 subjects retired before the initial visit. Therefore, 30 subjects were enrolled in the study. ... Five subjects dropped out from the study before the second visit; four females and one male. The reasons for not continuing in the study were as follows: one had medical reasons and four lost interest. There were no significant differences in the subject characteristics between those who completed...
- `study_design`: Quote: "single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial"
- `additional_notes`: Interventions: three arms (high dairy, high elemental calcium, control/placebo). Subjects in dairy group received provided dairy products monthly; elemental calcium group received 600 mg/d calcium carbonate supplement; control received placebo tablet. Subjects instructed to maintain isocaloric diet and usual physical activity. Compliance monitored by monthly calendar, food records, FFQ, and 24-h recall. Randomization process details (sequence generation) and allocation concealment not described.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Unclear risk | Low risk / Not applicable | no | blinding_outcome_type_or_role_confusion |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk / Not applicable | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | Not applicable / Unclear risk | yes |  |

### Audit Details

#### Random sequence generation

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: The report states the trial was randomized but provides no description of how the random sequence was generated. According to Cochrane criteria, insufficient information about the sequence generation process requires an 'Unclear risk' judgement.
- Model support: Comment: Randomization is stated ("randomized") but the method of sequence generation is not reported in the paper; no details (e.g. computer generator, random number table) are provided to judge adequacy.
- Model support context: [{"source": "methodology", "quote": "Quote: \"single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial\"", "relevance": "Shows the study is described as randomized, which is necessary but not sufficient to judge sequence generation."}, {"source": "methodology", "quote": "Interventions: three arms (high dairy, high elemental calcium, control/placebo)... Randomization process details (sequence generation) and allocation concealment not described.", "relevance": "Explicitly notes that sequence generation details were not reported, leaving uncertainty about whether a truly random method was used."}]
- GT support: Comment: mail from Dr Palacios: "The random sequence was computer generated"
- Evidence row: {}
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Because the paper provides no description of allocation concealment (e.g. central randomization, sealed envelopes) and randomization details are not reported, there is insufficient information to determine whether recruiters could have foreseen assignments; therefore the risk is unclear.
- Model support: Comment: The report does not describe the method used to conceal allocation (no information on central randomization, sealed envelopes, or other procedures); therefore it is unclear whether enrolment staff could foresee assignments.
- Model support context: [{"source": "methodology", "quote": "Randomization process details (sequence generation) and allocation concealment not described.", "relevance": "Direct statement that allocation concealment method was not reported, which is insufficient to judge risk."}, {"source": "methodology", "quote": "Quote: \"single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial\"", "relevance": "States trial was randomized and (partly) blinded but gives no details on how allocation was concealed prior to assignment."}]
- GT support: Comment: mail from Dr Palacios: "The random sequence was computer generated and the allocation concealment was performed centrally"
- Evidence row: {}
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Unclear risk
- Ground truth: Low risk / Not applicable
- Match: False
- Model rationale: Because the dairy arm was single-blinded and the intervention delivery (food vs tablets) likely made participant blinding incomplete, and there is no clear information that personnel interacting with participants were blinded, there is insufficient information to determine whether lack of blinding could have materially biased all outcomes; therefore risk is unclear.
- Model support: Quote: "We conducted a single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial for 21 wk..." Comment: The report states the trial was double-blind but notes it was single-blinded for the dairy group; personnel blinding is not described. Given the open aspects for the dairy arm (participants likely aware when provided dairy products) and lack of detail on whether personnel delivering interventions or assessing routine outcomes were blinded to group allocation, it is unclear whether performance bias was avoided. Probably not fully blinded for participants in the dairy group; unclear for personnel.
- Model support context: [{"source": "methodology", "quote": "\"We conducted a single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial for 21 wk...\"", "relevance": "States overall blinding claim but explicitly indicates only single blinding for the dairy group, suggesting participants (or personnel) may have been aware of allocation for that arm."}, {"source": "methodology", "quote": "Interventions: three arms (high dairy, high elemental calcium, control/placebo). Subjects in dairy group received provided dairy products monthly; elemental calcium group received 600 mg/d calcium carbonate supplement; control received placebo tablet.", "relevance": "Mode of intervention delivery (providing dairy products vs tablets) makes participant blinding difficult and raises risk of performance bias for participant-reported or behavior-influenced outcomes."}, {"source":...
- GT support: Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study" | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric...
- Evidence row: {}
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk / Not applicable
- Match: True
- Model rationale: The study explicitly states that CRC-trained personnel who performed measurements were blinded to treatment allocation; therefore outcome assessment was blinded and unlikely to be influenced by knowledge of intervention, meeting the criteria for low risk.
- Model support: Quote: "Measurements were taken while subjects wore light clothing, no shoes or accessories, by the CRC-trained personnel, who were blinded to the study treatments." Comment: Blinding of outcome assessment was implemented for the personnel who took measurements, so detection bias from assessors is unlikely.
- Model support context: [{"source": "methodology", "quote": "\"Measurements were taken while subjects wore light clothing, no shoes or accessories, by the CRC-trained personnel, who were blinded to the study treatments.\"", "relevance": "Direct statement that outcome assessors (CRC-trained personnel) were blinded to study treatments; supports low risk of detection bias for measured outcomes."}, {"source": "methodology", "quote": "\"single-center, randomized, double-blind (single-blinded for the dairy group), placebo-controlled trial\"", "relevance": "Overall trial described as double-blind (with single-blind aspect for one group), which supports the plausibility that assessors were masked and reduces risk of biased outcome measurement."}]
- GT support: Blind outcome assessors | Blind outcome assessors | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study." | Blind outcome assessors | Blind outcome assessors | Quote from publication: "The design of the study, a randomized, double-blinded" Comment: mail from Dr. Palacios: "All anthropometric measurements were done by the research staff of the Puerto Rico Clinical Research Center, who were blinded to the study."
- Evidence row: {}
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: Not applicable / Unclear risk
- Match: True
- Model rationale: Although overall attrition (5/30) and reasons are reported and seem partly unrelated to outcomes, absence of group-specific drop-out numbers and no description of how missing outcome data were handled prevents assessing whether missingness was balanced or could bias effect estimates; therefore risk is unclear.
- Model support: Quote: "Of the 46 subjects recruited, 10 did not qualify due to a calcium intake above 700 mg/d and 6 subjects retired before the initial visit. Therefore, 30 subjects were enrolled in the study. ... Five subjects dropped out from the study before the second visit; four females and one male. The reasons for not continuing in the study were as follows: one had medical reasons and four lost interest. There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who completed the study, 20 were female and 5 were male." Comment: Attrition is reported (5/30 dropped out, reasons given) but the report does not give loss to follow-up by randomized group, nor how missing outcome data were handled or imputed. Therefore there is insufficient information to judge whether missing data...
- Model support context: [{"source": "methodology", "quote": "\"Of the 46 subjects recruited, 10 did not qualify due to a calcium intake above 700 mg/d and 6 subjects retired before the initial visit. Therefore, 30 subjects were enrolled in the study. ... Five subjects dropped out from the study before the second visit; four females and one male. The reasons for not continuing in the study were as follows: one had medical reasons and four lost interest. There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who completed the study, 20 were female and 5 were male.\"", "relevance": "Provides the extent and reasons for attrition but lacks breakdown by randomized group and information on handling/imputation of missing outcomes."}, {"source": "methodology", "quote": "No further details on loss to...
- GT support: 20 participants randomised and 17 assessed | 20 participants randomised and 17 assessed | Quote from publication: "There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who completed the study, 20 were female and 5 were male. Within the ﬁve males, one was allocated to the high dairy group, two to the high calcium group, and two to the control group." Comment: attrition rates were 10% and 20% but relating to a small number of randomised participants (N = 10) in both groups | 20 participants randomised and 17 assessed | 20 participants randomised and 17 assessed | Quote from publication: "There were no significant differences in the subject characteristics between those who completed and those who did not complete the study (data not shown). Of the 25 subjects who...
- Evidence row: {}
- Source context preview: 


## 21775755 - Ziegler 2011

- Mode: strict
- Review context: none (0 chars)
- Article chars: 24371
- Extraction context chars: 12003
- Total seconds: 146.95

### Methodology Extraction

- `randomization_method`: "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six."
- `allocation_concealment_method`: "Screened patients were assigned a unique five-digit number. Randomized patients were additionally assigned a four-digit randomization number at baseline. The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency."
- `blinding_participants`: "randomized, double-blind, placebo-controlled"; "film-coated tablets containing 600 mg ALA ... or matching placebo tablets ... that were identical in appearance"
- `blinding_personnel`: "randomized, double-blind, placebo-controlled"; investigators had sealed envelopes to decode in case of emergency"
- `blinding_outcome_assessors`: "Experienced, trained, and certified (by P.J.D. and colleagues) physicians evaluated the NIS and NSC. Study physicians had participated in training sessions and actual examination of patients under observation using a formal certification process. The nerve conduction, quantitative sensory tests (QSTs), and autonomic tests were performed by trained and certified personnel (by P.A.L., W.J.L., P.J.D., and colleagues). All results were interactively evaluated by the Reading and Quality Assurance...
- `attrition_details`: Not reported
- `study_design`: Randomized, double-blind, placebo-controlled, two-arm, parallel-group clinical trial with 1:1 allocation
- `additional_notes`: Randomization used blocked randomization with block size of six (undisclosed block size of six); interim analysis planned with stopping rule (P < 0.005) and final alpha adjusted to 0.0452 (Šidák). Emergency unblinding via sealed envelopes held by investigators and monitor.

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Low risk | Low risk | yes |  |
| Blinding of participants and personnel: All outcomes | Low risk | Low risk | yes |  |
| Blinding of outcome assessment: All outcomes | Low risk | Low risk | yes |  |
| Incomplete outcome data: All outcomes | Unclear risk | High risk | no | under-called_due_to_missing_or_underused_evidence |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The sequence was generated by a Biostatistics Department using a randomization list with blocked randomization, which is an appropriate random method; therefore risk of bias from sequence generation is low.
- Model support: Quote: "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six." Comment: Probably done. A randomization list generated by a biostatistics department and use of blocked randomization constitutes a random component in sequence generation, meeting Low risk criteria.
- Model support context: [{"source": "methodology", "quote": "\"Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six.\"", "relevance": "Describes a random component (randomization list by biostatistics unit and blocked randomization), directly addressing sequence generation."}, {"source": "methodology", "quote": "\"Randomized, double-blind, placebo-controlled, two-arm, parallel-group clinical trial with 1:1 allocation\"", "relevance": "Confirms study design consistent with use of formal randomization procedures."}]
- GT support: Quote: "a randomization list was generated by the biostatistics department of the manufacturer of the study drug ..."
- Evidence row: {}
- Source context preview: 

#### Allocation concealment

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: Allocation sequence was generated centrally by an independent Biostatistics Department and participants received randomization numbers; emergency decoding was via sealed envelopes held only for emergencies. These features make it unlikely that recruiters could foresee assignments, meeting criteria for Low risk.
- Model support: Quote: "Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six." "Screened patients were assigned a unique five-digit number. Randomized patients were additionally assigned a four-digit randomization number at baseline. The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency." Comment: Probably done. A centrally generated randomization list by the independent Biostatistics Department plus procedures assigning randomization numbers and use of sealed emergency envelopes indicate allocation could not be foreseen by recruiters/enrollers.
- Model support context: [{"source": "methodology", "quote": "\"Patients were assigned to the two treatment groups according to a randomization list generated by the Biostatistics Department of MEDA Pharma. The random allocation was balanced using an undisclosed block size of six.\"", "relevance": "Shows random sequence generated centrally by an independent biostatistics unit, supporting concealment from recruiters."}, {"source": "methodology", "quote": "\"Screened patients were assigned a unique five-digit number. Randomized patients were additionally assigned a four-digit randomization number at baseline. The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.\"", "relevance": "Describes numbering and sealed emergency envelopes, indicating assignment was not openly predictable and emergency unblinding controlled."}]
- GT support: Quote: "a randomization list was generated by the biostatistics department of the manufacturer of the study drug, at distance of the centers the study took place"; "the random allocation was balanced using an undisclosed block size of six."
- Evidence row: {}
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The trial is described as double-blind with identical placebo tablets and only emergency sealed-envelope unblinding; outcome assessment was performed by trained/certified personnel with centralized evaluation. There is no indication the blind was likely broken or that lack of blinding would have materially biased outcomes, so risk of performance bias is low.
- Model support: Quote: "randomized, double-blind, placebo-controlled"; "film-coated tablets containing 600 mg ALA ... or matching placebo tablets ... that were identical in appearance" Comment: Blinding of participants and study personnel was implemented with matching placebo tablets and described as double-blind; emergency unblinding was possible via sealed envelopes but that is standard and does not indicate routine breaking of the blind. Probably done.
- Model support context: [{"source": "methodology", "quote": "\"randomized, double-blind, placebo-controlled\"; \"film-coated tablets containing 600 mg ALA ... or matching placebo tablets ... that were identical in appearance\"", "relevance": "Direct evidence that participants and personnel were blinded using identical placebo tablets."}, {"source": "methodology", "quote": "\"investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency.\"", "relevance": "Indicates emergency unblinding provision only, not routine unblinding, which supports maintained blinding."}, {"source": "methodology", "quote": "\"Experienced, trained, and certified ... physicians evaluated the NIS and NSC ... All results were interactively evaluated by the Reading and Quality Assurance Centers\"", "relevance": "Shows outcome assessment performed by trained/certified...
- GT support: Quote: "... matching placebo tablets with increased amounts of cellulose and lactose that were identical in appearance." Comment: trial described as double-blind.
- Evidence row: {}
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The trial is described as double-blind with matching placebo and objective assessments performed by trained personnel with central reading; there is no indication assessors were aware of allocations or that blinding was broken, so detection bias is unlikely.
- Model support: Quote: "randomized, double-blind, placebo-controlled"; "film-coated tablets containing 600 mg ALA ... or matching placebo tablets ... that were identical in appearance"; "Experienced, trained, and certified (by P.J.D. and colleagues) physicians evaluated the NIS and NSC. ... The nerve conduction, quantitative sensory tests (QSTs), and autonomic tests were performed by trained and certified personnel ... All results were interactively evaluated by the Reading and Quality Assurance Centers (at Mayo Clinic and Health Partners)." Comment: Blinding of outcome assessment was likely maintained (study described as double-blind, placebo identical in appearance, and assessments performed by trained/certified personnel with central reading/QA), so outcome measurement was unlikely to be influenced by knowledge of allocation. Probably done.
- Model support context: [{"source": "methodology", "quote": "\"randomized, double-blind, placebo-controlled\"; \"film-coated tablets containing 600 mg ALA ... or matching placebo tablets ... that were identical in appearance\"", "relevance": "Indicates participants and personnel (and thus likely assessors) were blinded and placebo matched, reducing risk that assessors knew allocation."}, {"source": "methodology", "quote": "\"Experienced, trained, and certified (by P.J.D. and colleagues) physicians evaluated the NIS and NSC... The nerve conduction, quantitative sensory tests (QSTs), and autonomic tests were performed by trained and certified personnel... All results were interactively evaluated by the Reading and Quality Assurance Centers (at Mayo Clinic and Health Partners).\"", "relevance": "Independent, certified assessors and central reading centres support objective outcome assessment and reduce likelihood...
- GT support: Quote: "The investigators and the monitor received sealed envelopes to enable decoding the individual blinded treatment in case of emergency."
- Evidence row: {}
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Unclear risk
- Ground truth: High risk
- Match: False
- Model rationale: Because the report provides no data on numbers lost to follow-up, reasons for missingness, or how missing data were handled, there is insufficient information to determine whether attrition could introduce material bias; thus the risk of bias is unclear.
- Model support: Comment: Attrition/missing outcome data are not reported in the available methodological information, so it is not possible to judge whether missing data were balanced, related to outcomes, or appropriately handled.
- Model support context: [{"source": "methodology", "quote": "attrition_details: \"Not reported\"", "relevance": "Direct statement that information on attrition/incomplete outcome data is not reported, which prevents assessment against the RoB criteria."}, {"source": "methodology", "quote": "\"Randomized, double-blind, placebo-controlled, two-arm, parallel-group clinical trial with 1:1 allocation\"", "relevance": "Study design indicates RCT but does not provide any attrition or handling information relevant to incomplete outcome data domain."}]
- GT support: More than 40% of participants discontinued intervention in both groups during the 4-year study. We do not know how many participants were lost before the outcomes at 2 years (our outcome of interest), and how many after the first 2 years. Most participants (454/460) were included in the ITT analysis, but the study authors did not report for how many they managed to measure the outcome, and for how many they used the last observation carried forward ("mean of weeks 191 and 192 or last available value after randomization"). Apparently, the proportion of dropouts and the causes of dropout were equally distributed among the 2 groups.
- Evidence row: {}
- Source context preview: 


## 22928960 - Houry 2012

- Mode: strict
- Review context: none (0 chars)
- Article chars: 20317
- Extraction context chars: 12006
- Total seconds: 140.55

### Methodology Extraction

- `randomization_method`: "We used computer-generated randomization to assign new reviewers to either the intervention or control group."
- `allocation_concealment_method`: Not reported
- `blinding_participants`: "All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors."
- `blinding_personnel`: Not reported
- `blinding_outcome_assessors`: Not reported
- `attrition_details`: "Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown)."
- `study_design`: Randomized controlled trial
- `additional_notes`: "Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups."; "Our main outcome measures were the mean review quality rating score for each reviewer, and the slope in change (improvement or deterioration) in editor-assigned reviewer quality ratings from their first review until the end date of the study. These were calculated from review scores recorded contemporaneously within our...

### Domain Judgements

| Domain | Pred | GT | Match | Error Type |
|---|---|---|---|---|
| Random sequence generation | Low risk | Low risk | yes |  |
| Allocation concealment | Unclear risk | Low risk | no | under-called_due_to_missing_or_underused_evidence |
| Blinding of participants and personnel: All outcomes | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |
| Blinding of outcome assessment: All outcomes | Low risk | Unclear risk | no | over-inferred_from_sparse_reporting |
| Incomplete outcome data: All outcomes | Low risk | Low risk | yes |  |

### Audit Details

#### Random sequence generation

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: The investigators explicitly report use of computer-generated randomization, which is an acceptable random method per Cochrane criteria and supports Low risk for random sequence generation.
- Model support: Quote: "We used computer-generated randomization to assign new reviewers to either the intervention or control group." Comment: Probably done — a computer-generated random sequence is a random component and meets the criteria for low risk of bias for sequence generation.
- Model support context: [{"source": "methodology", "quote": "\"We used computer-generated randomization to assign new reviewers to either the intervention or control group.\"", "relevance": "Explicit statement that sequence generation used a computer random generator, which is an appropriate random method."}, {"source": "methodology", "quote": "\"Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.\"", "relevance": "Indicates practical separation of invitation process from assignment, supporting that the random sequence was implemented without predictable allocation (relevant but pertains more to concealment)."}]
- GT support: Quote: "We used computer-generated randomization to assign new reviewers to either the intervention or control group."
- Evidence row: {}
- Source context preview: 

#### Allocation concealment

- Prediction: Unclear risk
- Ground truth: Low risk
- Match: False
- Model rationale: Random sequence generation was reported, but no details on how allocation was concealed from those enrolling participants were provided. Without explicit evidence (central allocation, sealed envelopes, etc.) that assignments could not be foreseen, the risk of selection bias is unclear.
- Model support: Comment: Allocation concealment method not reported. Although computer-generated randomization was used, there is no information indicating that allocation was implemented via a central system or otherwise concealed from those enrolling reviewers, so it is unclear whether enrolment could have been foreseen.
- Model support context: [{"source": "methodology", "quote": "\"We used computer-generated randomization to assign new reviewers to either the intervention or control group.\"", "relevance": "Shows a random sequence was generated but does not address whether allocations were concealed from recruiters/enrollers."}, {"source": "methodology", "quote": "allocation_concealment_method: \"Not reported\"", "relevance": "Direct statement that no information on allocation concealment was provided, which prevents judgement of whether assignments could be foreseen."}, {"source": "methodology", "quote": "\"Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.\"", "relevance": "Suggests editors/enrollers may not have known assignments, but this is an assertion without details of concealment processes (e.g....
- GT support: Computer-generated randomization and only a senior editor was aware of who was to receive the intervention.
- Evidence row: {}
- Source context preview: 

#### Blinding of participants and personnel: All outcomes

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: Reviewers were blinded in the journal's peer-review process and editors invited reviewers without knowledge of allocation; outcomes were editor-assigned scores recorded in software—together making it unlikely that lack of additional blinding would materially bias the results, so performance bias is judged low.
- Model support: Quote: "All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors." Comment: Study conduct indicates that reviewers were blinded to authors and peer review was blinded; editors invited reviewers without knowledge of group assignment. Outcomes (editor-assigned reviewer quality ratings recorded in editorial software) are unlikely to be materially biased by lack of participant/personnel blinding. Probably done.
- Model support context: [{"source": "methodology", "quote": "\"All peer review at our journal is blinded; however after a decision is made on each manuscript we routinely provide the reviewer blinded copies of all the comments of other reviewers on that paper, as well as a copy of the editor’s decision letter to the authors.\"", "relevance": "Indicates reviewers (participants) were blinded in the peer-review process, reducing risk that knowledge of allocation influenced their behaviour or self-reported outcomes."}, {"source": "methodology", "quote": "\"Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.\"", "relevance": "Suggests personnel who recruited/invited reviewers were unaware of allocation, reducing likelihood of differential treatment by staff."}, {"source": "methodology", "quote":...
- GT support: Quote: "Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups." Comment: personnel were blinded but unclear if participants were blinded.
- Evidence row: {}
- Source context preview: 

#### Blinding of outcome assessment: All outcomes

- Prediction: Low risk
- Ground truth: Unclear risk
- Match: False
- Model rationale: Editors who provided the quality ratings invited reviewers without knowledge of group assignment and ratings were recorded contemporaneously in software; therefore outcome measurement was unlikely to be influenced by knowledge of allocation, meeting criteria for low risk.
- Model support: Quote: "Our main outcome measures were the mean review quality rating score for each reviewer, and the slope in change (improvement or deterioration) in editor-assigned reviewer quality ratings from their first review until the end date of the study. These were calculated from review scores recorded contemporaneously within our editorial management software." Comment: Although explicit statement of blinding of outcome assessors is not reported, the outcomes were editor-assigned quality ratings recorded contemporaneously in editorial software and editors invited reviewers without knowledge of group assignment; these make it unlikely that outcome assessment was materially influenced by knowledge of intervention. Probably done.
- Model support context: [{"source": "methodology", "quote": "\"Our main outcome measures were the mean review quality rating score for each reviewer, and the slope in change (improvement or deterioration) in editor-assigned reviewer quality ratings from their first review until the end date of the study. These were calculated from review scores recorded contemporaneously within our editorial management software.\"", "relevance": "Shows outcomes were objective editor-assigned scores recorded contemporaneously, which reduces risk that assessor knowledge biased measurement."}, {"source": "methodology", "quote": "\"Over the course of the study editors invited reviewers in their standard fashion, without knowledge of which new reviewers were assigned to the mentorship or control groups.\"", "relevance": "Indicates editors who interacted with reviewers and made assessments were not aware of allocation, supporting...
- GT support: Quote: "All reviews at Annals are routinely rated by editors for quality on a previously reported 5-point scale that has demonstrated moderate reliability and is comparable to the scale validated by van Rooyen." Comment: unclear if the editors were aware of allocation when assessing the reviews.
- Evidence row: {}
- Source context preview: 

#### Incomplete outcome data: All outcomes

- Prediction: Low risk
- Ground truth: Low risk
- Match: True
- Model rationale: Only four randomized participants failed to receive the intervention and the authors report an ITT analysis with essentially identical results; the small, balanced (only in one arm but minor) and explained attrition is unlikely to produce a clinically relevant bias in effect estimates, so risk of bias from incomplete outcome data is low.
- Model support: Quote: "Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown)." Comment: The authors report a small number (four) of randomized participants who did not receive the intervention but state that an ITT analysis was performed and gave essentially identical results; the number missing is small and reasons are unlikely to be related to the outcome, so attrition is unlikely to introduce material bias. Probably done: intention-to-treat analysis performed and missing outcome impact minimal.
- Model support context: [{"source": "methodology", "quote": "\"Four subjects randomized to the mentorship group never made contact of any kind with their mentors, and thus did not receive the intended intervention. We therefore present below the per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown).\"", "relevance": "Provides the number and nature of missing/ non‑adherent participants and states that an ITT analysis was done with similar results, indicating missing data unlikely to bias outcomes materially."}]
- GT support: Quote: "per-protocol analysis excluding these four subjects; however we also performed a corresponding intention-to-treat analysis that yielded essentially identical results (data not shown)." Comment: 4 subjects in the intervention group did not receive the intervention and were excluded from the analysis. The researchers state that an ITT analysis "yielded essentially identical results" but the analyses are not included in the paper.
- Evidence row: {}
- Source context preview: 

## Workflow Evolution Notes

- Inspect mismatches where prediction is `Unclear risk` but GT is `Low risk`: these usually mean retrieval or Stage 1 extraction missed a concrete methodological phrase.
- Inspect mismatches where prediction is `Low risk` or `High risk` but GT is `Unclear risk`: these usually mean the prompt is allowing too much inference from generic trial language.
- For blinding mismatches, add outcome-type cues to the prompt: self-report outcomes, objective outcomes, assessor-administered outcomes, and whether lack of blinding can materially affect the outcome.
- For allocation concealment mismatches, require the model to distinguish sequence generation from concealment before assignment.